← Eichor
Study identifier: NCT02026388 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Rare Kidney Stone Consortium Biobank

Condition: Primary Hyperoxaluria · Dent Disease · APRT Deficiency  ·  Sponsor: Mayo Clinic

PhaseN/A
Planned participants2000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

This study is being done to obtain samples from patients with primary hyperoxaluria, cystinuria, adenine phosphoribosyl transferase (APRT) deficiency, and Dent disease, and from their family members, for use in future research.

This description comes directly from the study's public registry record.

Talk to the study team

Barb M Seide  ·  507-255-0387  ·  seide.barbara@mayo.edu

Leah M Knoke  ·  507-293-0467  ·  knoke.leah@mayo.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Mayo ClinicRochester, Minnesota, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02026388